The 60-hour brexanolone infusion treatment is expected to be available starting in June.
From https://www.huffpost.com/entry/fda-drug-postpartum-depression-brexanolone_n_5c91aad3e4b0dbf58e45a92d
from
https://healthnews010.wordpress.com/2019/03/20/fda-approves-first-drug-targeted-at-treating-postpartum-depression/
No comments:
Post a Comment